Pain Management Drugs Market 2028 By Therapeutics, Indication and Geography | The Insight Partners

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pain Management Drugs Market - By Therapeutics
1.3.2 Pain Management Drugs Market - By Indication
1.3.3 Pain Management Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PAIN MANAGEMENT DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. PAIN MANAGEMENT DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PAIN MANAGEMENT DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PAIN MANAGEMENT DRUGS - GLOBAL MARKET OVERVIEW
6.2. PAIN MANAGEMENT DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. PAIN MANAGEMENT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. ANTICONVULSANTS
7.3.1. Overview
7.3.2. Anticonvulsants Market Forecast and Analysis
7.4. ANTIDEPRESSANTS
7.4.1. Overview
7.4.2. Antidepressants Market Forecast and Analysis
7.5. ANESTHETICS
7.5.1. Overview
7.5.2. Anesthetics Market Forecast and Analysis
7.6. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
7.6.1. Overview
7.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS) Market Forecast and Analysis
7.7. OPIOIDS
7.7.1. Overview
7.7.2. Opioids Market Forecast and Analysis
7.7.3. Tramadol Market
7.7.3.1. Overview
7.7.3.2. Tramadol Market Forecast and Analysis
7.7.4. Hydrocodone Market
7.7.4.1. Overview
7.7.4.2. Hydrocodone Market Forecast and Analysis
7.7.5. Oxycodone Market
7.7.5.1. Overview
7.7.5.2. Oxycodone Market Forecast and Analysis
7.7.6. Others Market
7.7.6.1. Overview
7.7.6.2. Others Market Forecast and Analysis
7.8. ANTIMIGRAINE AGENTS
7.8.1. Overview
7.8.2. Antimigraine Agents Market Forecast and Analysis
7.9. OTHER NON-NARCOTIC ANALGESIC
7.9.1. Overview
7.9.2. Other Non-narcotic Analgesic Market Forecast and Analysis
8. PAIN MANAGEMENT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. NEUROPATHIC PAIN
8.3.1. Overview
8.3.2. Neuropathic Pain Market Forecast and Analysis
8.4. FIBROMYALGIA
8.4.1. Overview
8.4.2. Fibromyalgia Market Forecast and Analysis
8.5. ARTHRITIC PAIN
8.5.1. Overview
8.5.2. Arthritic Pain Market Forecast and Analysis
8.6. CHRONIC BACK PAIN
8.6.1. Overview
8.6.2. Chronic Back Pain Market Forecast and Analysis
8.7. MIGRAINE
8.7.1. Overview
8.7.2. Migraine Market Forecast and Analysis
8.8. POST-OPERATIVE PAIN
8.8.1. Overview
8.8.2. Post-Operative Pain Market Forecast and Analysis
8.9. CANCER PAIN
8.9.1. Overview
8.9.2. Cancer Pain Market Forecast and Analysis

9. PAIN MANAGEMENT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pain Management Drugs Market Overview
9.1.2 North America Pain Management Drugs Market Forecasts and Analysis
9.1.3 North America Pain Management Drugs Market Forecasts and Analysis - By Therapeutics
9.1.4 North America Pain Management Drugs Market Forecasts and Analysis - By Indication
9.1.5 North America Pain Management Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pain Management Drugs Market
9.1.5.1.1 United States Pain Management Drugs Market by Therapeutics
9.1.5.1.2 United States Pain Management Drugs Market by Indication
9.1.5.2 Canada Pain Management Drugs Market
9.1.5.2.1 Canada Pain Management Drugs Market by Therapeutics
9.1.5.2.2 Canada Pain Management Drugs Market by Indication
9.1.5.3 Mexico Pain Management Drugs Market
9.1.5.3.1 Mexico Pain Management Drugs Market by Therapeutics
9.1.5.3.2 Mexico Pain Management Drugs Market by Indication
9.2. EUROPE
9.2.1 Europe Pain Management Drugs Market Overview
9.2.2 Europe Pain Management Drugs Market Forecasts and Analysis
9.2.3 Europe Pain Management Drugs Market Forecasts and Analysis - By Therapeutics
9.2.4 Europe Pain Management Drugs Market Forecasts and Analysis - By Indication
9.2.5 Europe Pain Management Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pain Management Drugs Market
9.2.5.1.1 Germany Pain Management Drugs Market by Therapeutics
9.2.5.1.2 Germany Pain Management Drugs Market by Indication
9.2.5.2 France Pain Management Drugs Market
9.2.5.2.1 France Pain Management Drugs Market by Therapeutics
9.2.5.2.2 France Pain Management Drugs Market by Indication
9.2.5.3 Italy Pain Management Drugs Market
9.2.5.3.1 Italy Pain Management Drugs Market by Therapeutics
9.2.5.3.2 Italy Pain Management Drugs Market by Indication
9.2.5.4 Spain Pain Management Drugs Market
9.2.5.4.1 Spain Pain Management Drugs Market by Therapeutics
9.2.5.4.2 Spain Pain Management Drugs Market by Indication
9.2.5.5 United Kingdom Pain Management Drugs Market
9.2.5.5.1 United Kingdom Pain Management Drugs Market by Therapeutics
9.2.5.5.2 United Kingdom Pain Management Drugs Market by Indication
9.2.5.6 Rest of Europe Pain Management Drugs Market
9.2.5.6.1 Rest of Europe Pain Management Drugs Market by Therapeutics
9.2.5.6.2 Rest of Europe Pain Management Drugs Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pain Management Drugs Market Overview
9.3.2 Asia-Pacific Pain Management Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Pain Management Drugs Market Forecasts and Analysis - By Therapeutics
9.3.4 Asia-Pacific Pain Management Drugs Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Pain Management Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pain Management Drugs Market
9.3.5.1.1 Australia Pain Management Drugs Market by Therapeutics
9.3.5.1.2 Australia Pain Management Drugs Market by Indication
9.3.5.2 China Pain Management Drugs Market
9.3.5.2.1 China Pain Management Drugs Market by Therapeutics
9.3.5.2.2 China Pain Management Drugs Market by Indication
9.3.5.3 India Pain Management Drugs Market
9.3.5.3.1 India Pain Management Drugs Market by Therapeutics
9.3.5.3.2 India Pain Management Drugs Market by Indication
9.3.5.4 Japan Pain Management Drugs Market
9.3.5.4.1 Japan Pain Management Drugs Market by Therapeutics
9.3.5.4.2 Japan Pain Management Drugs Market by Indication
9.3.5.5 South Korea Pain Management Drugs Market
9.3.5.5.1 South Korea Pain Management Drugs Market by Therapeutics
9.3.5.5.2 South Korea Pain Management Drugs Market by Indication
9.3.5.6 Rest of Asia-Pacific Pain Management Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Pain Management Drugs Market by Therapeutics
9.3.5.6.2 Rest of Asia-Pacific Pain Management Drugs Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pain Management Drugs Market Overview
9.4.2 Middle East and Africa Pain Management Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Pain Management Drugs Market Forecasts and Analysis - By Therapeutics
9.4.4 Middle East and Africa Pain Management Drugs Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Pain Management Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pain Management Drugs Market
9.4.5.1.1 South Africa Pain Management Drugs Market by Therapeutics
9.4.5.1.2 South Africa Pain Management Drugs Market by Indication
9.4.5.2 Saudi Arabia Pain Management Drugs Market
9.4.5.2.1 Saudi Arabia Pain Management Drugs Market by Therapeutics
9.4.5.2.2 Saudi Arabia Pain Management Drugs Market by Indication
9.4.5.3 U.A.E Pain Management Drugs Market
9.4.5.3.1 U.A.E Pain Management Drugs Market by Therapeutics
9.4.5.3.2 U.A.E Pain Management Drugs Market by Indication
9.4.5.4 Rest of Middle East and Africa Pain Management Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Pain Management Drugs Market by Therapeutics
9.4.5.4.2 Rest of Middle East and Africa Pain Management Drugs Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pain Management Drugs Market Overview
9.5.2 South and Central America Pain Management Drugs Market Forecasts and Analysis
9.5.3 South and Central America Pain Management Drugs Market Forecasts and Analysis - By Therapeutics
9.5.4 South and Central America Pain Management Drugs Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Pain Management Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pain Management Drugs Market
9.5.5.1.1 Brazil Pain Management Drugs Market by Therapeutics
9.5.5.1.2 Brazil Pain Management Drugs Market by Indication
9.5.5.2 Argentina Pain Management Drugs Market
9.5.5.2.1 Argentina Pain Management Drugs Market by Therapeutics
9.5.5.2.2 Argentina Pain Management Drugs Market by Indication
9.5.5.3 Rest of South and Central America Pain Management Drugs Market
9.5.5.3.1 Rest of South and Central America Pain Management Drugs Market by Therapeutics
9.5.5.3.2 Rest of South and Central America Pain Management Drugs Market by Indication

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PAIN MANAGEMENT DRUGS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ENDO INTERNATIONAL PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ASTRAZENECA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LILLY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JOHNSON AND JOHNSON
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MALLINCKRODT
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVARTIS AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MERCK SHARP AND DOHME CORP
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS